ArticleReproductive medicine and biology2017

Phase III trial comparing the efficacy and safety of recombinant- or urine-derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo-ovulation and undergoing ovulation induction with follitropin-alfa.

Hideyuki Ikenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.